Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Instil Bio, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 31 | 30 | −1 |
| Shares | 4.25M | 4.23M | −19.9K (−0.5%) |
| Value | $45.9M | $43.5M | −$2.37M (−5.2%) |
New holders (3)
Institutions that held Instil Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 625 | $6.43K | 0.00% |
| Jones Financial Companies LLLP | 500 | $5.14K | 0.00% |
| Royal Bank of Canada | 171 | $2.00K | 0.00% |
Sold out (4)
Institutions that held Instil Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Squarepoint Ops LLC | 17,367 | $187.6K |
| Citadel Advisors LLC | 15,438 | $166.7K |
| Wells Fargo & Company | 31 | $335 |
| Advisor Group Holdings, Inc. | 13 | $140 |